| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |